A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

Sponsor
National University Hospital, Singapore
Study ID
NCT07481019
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
16 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Flexible ePROM-guided Scheduling System — BEHAVIORAL
    Monthly ePROM responses will feed a Bayesian decision system to determine appointment need, which will then be used to make recommendations to patients for scheduling of appointments.
  • electronic patient reported outcome measures (ePROMs) — BEHAVIORAL
    Monthly electronic patient reported outcome measures (ePROMs) surveys will be sent to patients' mobile devices to capture self-reported disease severity data.

Study Details

The goal of this clinical trial is to evaluate whether an electronic patient-reported outcome measure (ePROM)-guided flexible scheduling system can improve outpatient clinic resource utilisation in patients attending dermatology outpatient clinics for routine follow-up. The main questions it aims to answer are: * Does the intervention reduce the number of actualised outpatient visits over 12 months compared with standard fixed scheduling? * Does the intervention group achieve higher adherence to monthly ePROM monitoring, as measured by the proportion of completed ePROM submissions?

Key Dates

First listed
Mar 18, 2026
Start date
Sep 30, 2026
Status verified
Mar 2026
Primary completion
Jun 30, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
250 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Intervention Arm
    Participants in the intervention arm will not receive routine follow-up appointments at the end of their consultation. Instead, their monthly ePROM responses will feed a two-layer Bayesian decision system to determine appointment need.
  • Active Comparator: Control Arm
    Participants in the control arm will continue standard care, with follow-up appointments scheduled at the end of each consultation. The ePROM responses may be used by patients for self-tracking and will be available to clinicians to inform decision-making at subsequent visits.

Primary Outcome Measure

Number of actualised outpatient visits [ Time Frame: baseline to week 52 ]

Central Contacts

Find similar trials

Nationwide
Atopic dermatitis / eczema trialsPsoriasis trialsDermatology trialsRheumatology trialsAutoimmune disease trials

Related Studies